Related references
Note: Only part of the references are listed.Multidrug-Resistant Acinetobacter baumannii Infections in the United Kingdom versus Egypt: Trends and Potential Natural Products Solutions
Wafaa H. Elwakil et al.
ANTIBIOTICS-BASEL (2023)
Analysis of Efflux Pump System and Other Drug Resistance Related Gene Mutations in Tigecycline-Resistant Acinetobacter baumannii
Wenzheng Zheng et al.
Computational and Mathematical Methods in Medicine (2023)
Clonal spread of ArmA- and OXA-23-coproducing Acinetobacter baumannii International Clone 2 in Brazil during the first wave of the COVID-19 pandemic
Carlos Henrique Camargo et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2022)
Assessing Clinical Potential of Old Antibiotics against Severe Infections by Multi-Drug-Resistant Gram-Negative Bacteria Using In Silico Modelling
Paschalis Paranos et al.
PHARMACEUTICALS (2022)
Genetic Configuration of Genomic Resistance Islands in Acinetobacter baumannii Clinical Isolates From Egypt
Samira M. Hamed et al.
FRONTIERS IN MICROBIOLOGY (2022)
Tn7382, a novel composite transposon harboring blaNDM-1 and aphA6 in Acinetobacter baumannii
Samira M. Hamed et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2022)
Genomic Analysis of Acinetobacter baumannii Isolates Carrying OXA-23 and OXA-58 Genes from Animals Reveals ST1 and ST25 as Major Clonal Lineages
Lisa Jacobmeyer et al.
ANTIBIOTICS-BASEL (2022)
Coexistence of blaNDM-1, blaOXA-51, blaOXA-23, and armA in conjunction with novel mutations detected in RND efflux pump regulators in tigecycline resistant clinical isolates of Acinetobacter baumannii
Ajit Ramesh Sawant et al.
PATHOGENS AND DISEASE (2022)
Decreased carO gene expression and OXA-type carbapenemases among extensively drug-resistant Acinetobacter baumannii strains isolated from burn patients in Tehran, Iran
Elham Abbasi et al.
ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA (2021)
Molecular Epidemiology and Clone Transmission of Carbapenem-Resistant Acinetobacter baumannii in ICU Rooms
Xiufeng Zhang et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii From Khartoum State, Sudan
Leena Al-Hassan et al.
FRONTIERS IN MICROBIOLOGY (2021)
Overexpression of Efflux Pumps, Mutations in the Pumps' Regulators, Chromosomal Mutations, and AAC(6′)-Ib-cr Are Associated With Fluoroquinolone Resistance in Diverse Sequence Types of Neonatal Septicaemic Acinetobacter baumannii: A 7-Year Single Center Study
Subhasree Roy et al.
FRONTIERS IN MICROBIOLOGY (2021)
Impact of target site mutations and plasmid associated resistance genes acquisition on resistance of Acinetobacter baumannii to fluoroquinolones
Mostafa Ahmed Mohammed et al.
SCIENTIFIC REPORTS (2021)
Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Isolates from Northern Africa and the Middle East
Paul G. Higgins et al.
ANTIBIOTICS-BASEL (2021)
Genomic Characterization of Extensively Drug-Resistant NDM-Producing Acinetobacter baumannii Clinical Isolates With the Emergence of Novel blaADC-257
Mai M. Zafer et al.
FRONTIERS IN MICROBIOLOGY (2021)
Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt
Deena Jalal et al.
MSPHERE (2021)
Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital-acquired infections: a scientific review
M. Nguyen et al.
JOURNAL OF APPLIED MICROBIOLOGY (2021)
Predominance of international clone 2 multidrug-resistant Acinetobacter baumannii clinical isolates in Thailand: a nationwide study
Piyatip Khuntayaporn et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2021)
Acinetobacter baumannii Antibiotic Resistance Mechanisms
Ioannis Kyriakidis et al.
PATHOGENS (2021)
WGS-Based Analysis of Carbapenem-Resistant Acinetobacter baumannii in Vietnam and Molecular Characterization of Antimicrobial Determinants and MLST in Southeast Asia
Gamal Wareth et al.
ANTIBIOTICS-BASEL (2021)
Molecular characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates from Egyptian patients
Reem M. Hassan et al.
PLOS ONE (2021)
Multidrug Resistant Acinetobacter baumannii Biofilms: Evaluation of Phenotypic-Genotypic Association and Susceptibility to Cinnamic and Gallic Acids
Mahmoud M. Sherif et al.
FRONTIERS IN MICROBIOLOGY (2021)
Molecular Characterization of German Acinetobacter baumannii Isolates and Multilocus Sequence Typing (MLST) Analysis Based on WGS Reveals Novel STs
Gamal Wareth et al.
PATHOGENS (2021)
Diversity of International High-Risk Clones of Acinetobacter baumannii Revealed in a Russian Multidisciplinary Medical Center during 2017-2019
Andrey Shelenkov et al.
ANTIBIOTICS-BASEL (2021)
Co-Existence of Carbapenemase-Encoding Genes in Acinetobacter baumannii from Cancer Patients
Reham Wasfi et al.
INFECTIOUS DISEASES AND THERAPY (2021)
First identification of blaNDM-1 carbapenemase in blaOXA-94-producing Acinetobacter baumannii ST85 in Spain
Felipe Fernandez-Cuenca et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2020)
Fluoroquinolone resistance conferred by gyrA, parC mutations, and AbaQ efflux pump among Acinetobacter baumannii clinical isolates causing ventilator-associated pneumonia
Nancy M. Attia et al.
ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA (2020)
Tigecycline efflux in Acinetobacter baumannii is mediated by TetA in synergy with RND-type efflux transporters
Wuen Ee Foong et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
In Vivo Cross-Linking MS Reveals Conservation in OmpA Linkage to Different Classes of β-Lactamase Enzymes
Xuefei Zhong et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2020)
Colistin-Resistant Acinetobacter Baumannii Bacteremia: A Serious Threat for Critically Ill Patients
Georgios Papathanakos et al.
MICROORGANISMS (2020)
Phenotypic and WGS-derived antimicrobial resistance profiles of clinical and non-clinical Acinetobacter baumannii isolates from Germany and Vietnam
Gamal Wareth et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Acinetobacter baumannii Resistance: A Real Challenge for Clinicians
Rosalino Vazquez-Lopez et al.
ANTIBIOTICS-BASEL (2020)
Molecular Characterization of Carbapenem/Colistin-Resistant Acinetobacter baumannii Clinical Isolates from Egypt by Whole-Genome Sequencing
Nevine S. Fam et al.
INFECTION AND DRUG RESISTANCE (2020)
First Report of New Delhi Metallo-β-Lactamase-6 (NDM-6) in a Clinical Acinetobacter baumannii Isolate From Northern Spain
Kyriaki Xanthopoulou et al.
FRONTIERS IN MICROBIOLOGY (2020)
Integrons and Antiseptic Resistance Genes Mediate Resistance of Acinetobacter baumannii and Pseudomonas aeruginosa Isolates from Intensive Care Unit Patients with Wound Infections
Walid F. Elkhatib et al.
CURRENT MOLECULAR MEDICINE (2019)
Managing Acinetobacter baumannii infections
Jose Garnacho-Montero et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2019)
Acinetobacter baumannii analysis by core genome multi-locus sequence typing in two hospitals in Bolivia: endemicity of international clone 7 isolates (CC25)
Monica Cerezales et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans
Tao He et al.
NATURE MICROBIOLOGY (2019)
Carbapenem-resistant Acinetobacter baumannii in patients with burn injury: A systematic review and meta-analysis
William Gustavo Lima et al.
BURNS (2019)
Plasmid-encoded tet(X) genes that confer high-level tigecycline resistance in Escherichia coli
Jian Sun et al.
NATURE MICROBIOLOGY (2019)
Validating the AMRFinder Tool and Resistance Gene Database by Using Antimicrobial Resistance Genotype-Phenotype Correlations in a Collection of Isolates
Michael Feldgarden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Multiple sequence types responsible for healthcare-associated Acinetobacter baumannii dissemination in a single centre in Egypt
Leena Al-Hassan et al.
BMC INFECTIOUS DISEASES (2019)
Role of insertion sequence Aba-1 and AdeS in reduced tigecycline susceptibility in MDR-Acinetobacter baumannii clinical isolates from Cairo, Egypt
Reem Hassan et al.
JOURNAL OF CHEMOTHERAPY (2018)
Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-econtrol study
Chung-Ting Chen et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2018)
Uncovering the mechanisms of Acinetobacter baumannii virulence
Christian M. Harding et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Whole-genome sequencing of NDM-1-producing ST85 Acinetobacter baumannii isolates from Tunisia
Nadia Jaidane et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Egypt: Clonal Spread of blaOXA-23
Afaf Mohamed Samy El Bannah et al.
MICROBIAL DRUG RESISTANCE (2018)
Incidence of OXA-23 and OXA-58 Carbapenemases Coexpressed in Clinical Isolates of Acinetobacter baumannii in Tunisia
Najla Mathlouthi et al.
MICROBIAL DRUG RESISTANCE (2018)
Genomic mapping of ST85 blaNDM-1 and blaOXA-94 producing Acinetobacter baumannii isolates from Syrian Civil War Victims
Tamara Salloum et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2018)
Multiple mechanisms contributing to ciprofloxacin resistance among Gram negative bacteria causing infections to cancer patients
Samira M. Hamed et al.
SCIENTIFIC REPORTS (2018)
Carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: characterization of carbapenemase genes and E-test evaluation of colistin-based combinations
Raghdaa A. Ramadan et al.
INFECTION AND DRUG RESISTANCE (2018)
CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database
Baofeng Jia et al.
NUCLEIC ACIDS RESEARCH (2017)
Synergy against extensively drug-resistant Acinetobacter baumannii in vitro by two old antibiotics: colistin and chloramphenicol
Wen-juan Wei et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
The emergence of a novel sequence type of MDR Acinetobacter baumannii from the intensive care unit of an Egyptian tertiary care hospital
Doaa Mohammad Ghaith et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2017)
A new subclass of intrinsic aminoglycoside nucleotidyltransferases, ANT(3)-II, is horizontally transferred among Acinetobacter spp. by homologous recombination
Gang Zhang et al.
PLOS GENETICS (2017)
Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options
Chang-Ro Lee et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Clinical and Epidemiological Significance of Carbapenem Resistance in Acinetobacter baumannii Infections
Ruthy Tal-Jasper et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates
Martha Nepka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Early detection of metallo-β-lactamase NDM-1-and OXA-23 carbapenemase-producing Acinetobacter baumannii in Libyan hospitals
Najla Mathlouthi et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
PHYLOViZ Online: web-based tool for visualization, phylogenetic inference, analysis and sharing of minimum spanning trees
Bruno Ribeiro-Goncalves et al.
NUCLEIC ACIDS RESEARCH (2016)
The Ribosomal S10 Protein Is a General Target for Decreased Tigecycline Susceptibility
Kathryn Beabout et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
High Prevalence of blaNDM-1 Carbapenemase-Encoding Gene and 16S rRNA armA Methyltransferase Gene among Acinetobacter baumannii Clinical Isolates in Egypt
Mohamed Abd El-Gawad El-Sayed-Ahmed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
The transferability of blaOXA-23 gene in multidrug-resistant Acinetobacter baumannii isolates from Saudi Arabia and Egypt
Bruno Silvester Lopes et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2015)
Acinetobacter baumannii Repeatedly Evolves a Hypermutator Phenotype in Response to Tigecycline That Effectively Surveys Evolutionary Trajectories to Resistance
Troy G. Hammerstrom et al.
PLOS ONE (2015)
Prokka: rapid prokaryotic genome annotation
Torsten Seemann
BIOINFORMATICS (2014)
RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies
Alexandros Stamatakis
BIOINFORMATICS (2014)
Role of the BaeSR two-component system in the regulation of Acinetobacter baumannii adeAB genes and its correlation with tigecycline susceptibility
Ming-Feng Lin et al.
BMC MICROBIOLOGY (2014)
Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt
Mohamed H. Al-Agamy et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2014)
Amikacin resistance plasmids in extensively antibiotic-resistant GC2 Acinetobacter baumannii from two Australian hospitals
Steven J. Nigro et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Multidrug-resistant Acinetobacter baumannii strains carrying the blaOXA-23 and the blaGES-11 genes in a neonatology center in Tunisia
Karama Charfi-Kessis et al.
MICROBIAL PATHOGENESIS (2014)
Effects of Group 1 versus Group 2 Carbapenems on the Susceptibility of Acinetobacter baumannii to Carbapenems: A Before and After Intervention Study of Carbapenem-Use Stewardship
Young Kyung Yoon et al.
PLOS ONE (2014)
Origin in Acinetobacter guillouiae and Dissemination of the Aminoglycoside-Modifying Enzyme Aph(3′)-VI
Eun-Jeong Yoon et al.
MBIO (2014)
RND-Type Efflux Pumps in Multidrug-Resistant Clinical Isolates of Acinetobacter baumannii: Major Role for AdeABC Overexpression and AdeRS Mutations
Eun-Jeong Yoon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Spread of Carbapenem-Resistant Acinetobacter baumannii Global Clone 2 in Asia and AbaR-Type Resistance Islands
Dae Hun Kim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
QUAST: quality assessment tool for genome assemblies
Alexey Gurevich et al.
BIOINFORMATICS (2013)
Study of the carbapenem resistance mechanisms in clinical isolates of Acinetobacter baumannii: Comparison of burn and non-burn strains
Omid Pajand et al.
BURNS (2013)
Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages
Raffaele Zarrilli et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility
Esther Zander et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Structural basis for potent inhibitory activity of the antibiotic tigecycline during protein synthesis
Lasse Jenner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii
Nabil Karah et al.
DRUG RESISTANCE UPDATES (2012)
Identification of acquired antimicrobial resistance genes
Ea Zankari et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Role of ISAba1 and ISAba125 in governing the expression of blaADC in clinically relevant Acinetobacter baumannii strains resistant to cephalosporins
B. S. Lopes et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Efflux-Mediated Antibiotic Resistance in Acinetobacter spp.
Sebastien Coyne et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The pmrCAB Operon Mediates Polymyxin Resistance in Acinetobacter baumannii ATCC 17978 and Clinical Isolates through Phosphoethanolamine Modification of Lipid A
Luis A. Arroyo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance
Neil Woodford et al.
FEMS MICROBIOLOGY REVIEWS (2011)
Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
Jennifer H. Moffatt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Global spread of carbapenem-resistant Acinetobacter baumannii
Paul G. Higgins et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii
Michael Hornsey et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
The Population Structure of Acinetobacter baumannii: Expanding Multiresistant Clones from an Ancestral Susceptible Genetic Pool
Laure Diancourt et al.
PLOS ONE (2010)
Acinetobacter baumannii:: Emergence of a successful pathogen
Anton Y. Peleg et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Carbapenems: a potent class of antibiotics
David P. Nicolau
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species
Jane F. Turton et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome
AS Leung et al.
CHEST (2006)
Tigecycline: what is it, and where should it be used?
DM Livermore
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Tigecycline is modified by the flavin-dependent monooxygenase TetX
IF Moore et al.
BIOCHEMISTRY (2005)
Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 β-lactamase:: Defining a unique family of class C enzymes
KM Hujer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii:: Natural Insertional inactivation of a gene encoding a member of a novel family of β-barrel outer membrane proteins
MA Mussi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Mutations in the gyrA and parC genes in ciprofloxacin-resistant clinical isolates of Acinetobacter baumannii in Korea
JK Lee et al.
MICROBIOLOGY AND IMMUNOLOGY (2005)
Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92
HM Donald et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
